Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Drilling Update

21 Feb 2011 07:00

RNS Number : 5102B
Ovoca Gold PLC
21 February 2011
 



Ovoca Gold PLC

21 February 2011

 

Ovoca Gold plc ("Ovoca" or the "Company")

Zet target identified following trench work

 

 

 

Ovoca announces it has completed analysis of its trench program on Zet from the 2010 exploration season. Zet is located 35 kilometers north of Olcha and it is approximately 30 kilometers southeast of Podgorniy, a gold-silver target earlier identified and announced by the Company on 15 November 2010.

 

Zet is an epithermal vein system that occupies an area of 40 square kilometres. The gold-silver mineralisation is hosted by altered Devonian volcanogenic rock. The alteration zone has width of 1 to 2 km and a strike of 7 km in NE direction. Ovoca dug 1,844 metres of trenches in 2010 and historically 5,982 metres of trench work was completed prior to Ovoca's acquisition of the Rassoshinskaya license. 20 veins have been identified by trenching. The veins vary in length from 100 to 1,900 metres, and are between 1 and 4 metres wide with grades up to 20 g/t gold.

 

Bore hole ID number

Target

Length, m

True thickness, m

Gold grade, g/t

Silver grade, g/t

K-8-Z*

Vein #1

3.8

3.71

2.0

12.5

K1-Z*

Vein #1

1.5

1.41

0.7

5.5

K-8

Vein #1

2.5

2.41

3.2

17.2

K-BK-5

Vein #1

0.4

0.38

4.7

0.0

K-BK-2

Vein #1

1.0

1.00

3.4

33.5

K-2

Vein #1

1.9

1.84

2.7

14.2

K-BK-7

Vein #1

0.7

0.70

1.9

0.0

K-BK-5

Vein #2

1.0

0.95

6.2

8.2

TR-1

Vein #2

3.0

2.90

2.6

17.0

K-BK-7

Vein #2

0.5

0.47

20.6

14.0

SP-2

Vein #2

4.0

3.88

10.5

60.5

K-1-Z*

Vein #3

0.6

0.59

6.6

80.6

K-BK-14

Vein #3

0.7

0.69

4.0

12.0

K-BK-5

Vein #3

0.1

0.10

2.0

0.0

K-2-Z*

Vein #3

1.0

0.75

8.0

10.8

K-BK-7

Vein Zone #6

1.2

1.20

3.7

3.4

K-6-Z*

Vein Zone #6

3.7

3.52

4.1

29.9

K-BK-9

Vein Zone #6

3.0

2.99

1.6

15.0

K-BK-11

Vein #8

3.9

3.77

12.5

22.4

*Denotes trenches completed by Ovoca Gold in 2010

 

 

Tim McCutcheon, CEO, comments: "Zet is the latest target that has been identified by the Ovoca team on the Rassoshinskaya license area. Despite being one license, Rassoshinskaya's 2,460 square kilometers area is substantial and is in a very prospective region for gold discoveries. Given past historical work and our work in 2010, we have combined over 8,000 meters of trench work, plus detailed mapping, geophysics and geochemical data on Zet. Ovoca's plan is to drill on Zet in order to establish that the vein outcroppings, which have been thoroughly tested by trenching, extend to depth."

 

Notes to Editors

Ovoca Gold PLC ("Ovoca" or "the Company") is a mineral exploration and mine development company listed on the AIM market of the London Stock Exchange (Ticker: OVG) and on the ESM market of the Irish Stock Exchange (Ticker: OVX). The Companys principal activity is gold exploration in the Magadan Region of the Russian Federation. Previously Ovoca acquired, developed and sold to JSC Polymetal for US$47.7 million at the time of closing the Goltsovoye silver project located in the Magadan Region. Currently, Ovoca is aggressively exploring and developing its 100 per cent owned Stakhanovsky, Rassoshinskaya and Nevsko-Pestrinskoye licenses.

 

Stakhanovsky is located approximately 40 kilometres north of Susuman, the second largest city in the Magadan region. It is accessible by year-round road and there is power infrastructure on site. The Company intends to put Stakhanovsky into production by 2013.

 

Rassoshinskaya is in the North Eastern part of the Magadan Region about 200 kilometres from the town of Simchan. There is no nearby infrastructure. Rassoshinskaya hosts an epithermal gold deposit named Olcha, as well as other

gold and gold-silver targets. Olcha and nearby satellite deposits have the potential to host a high grade multi-million ounce gold resource.

 

Nevsko-Pestrinskoye is located in the central part of the Magadan region near the town of Omsukchan. A year-round road and powerline are near the site. The license completely surrounds the Goltsovoye silver deposit. Ovoca intends to investigate and explore known mineral occurrences that extend beyond the Goltsovoye license area onto Nevsko-Pestrinskoye.

 

Ovoca Gold Plc

 

Timothy McCutcheon +7 495 916 6029 tim.mccutcheon@ovocagold.com

 

Davy

 

John Frain +353 1 679 6363

 

 

The above information has been reviewed and verified by Mr. Andrew W. Aitchison for the purposes of the Guidance Note for Mining, Oil and Gas Companies issued by the London Stock Exchange in March 2006. Mr. Aitchison, MAusIMM, FGS from the University of Newcastle, Australia, is Ovoca Gold's Consulting Geologist and he has over 20 years experience of gold and base metal mining and exploration in Australia, Turkey, Ghana, Russia and Kazakhstan. Experience includes operational and management roles at the Pajingo and Ovacik gold mines, as well as Manager Mineral Resources and Mine Planning for Goldfields in Ghana. Further details about the Podgorniy gold project are found in the following technical reports (i) SRK Consulting Technical Report, June 2009, (ii) SRK Consulting Field Review, September 2009 which can be found in the Ovoca circular to shareholders dated 22 December 2009 on our website www.ovocagold.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DRLEADAPFSFFEFF
Date   Source Headline
29th Jul 20227:00 amRNSCompletion of Enrollment in Phase II Study
30th Jun 20227:00 amRNSAnnual Financial Report
7th Mar 20229:00 amRNSStatement re Russian Business Operations
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20223:30 pmRNSRussian Marketing Authorisation for Orenetide
31st Jan 20227:00 amRNSBoard Changes and Update
30th Dec 20217:00 amRNSDirectorate Change
4th Nov 20213:53 pmRNSHolding(s) in Company
4th Nov 20213:50 pmRNSDirector/PDMR Shareholding
4th Nov 20213:46 pmRNSBoard Change
14th Sep 20217:00 amRNSInterim Results
29th Jul 20215:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAnnual Report and Notice of AGM
10th Mar 20217:00 amRNSMigration of Participating Securities
16th Feb 20212:00 pmRNSResult of EGM
29th Jan 20217:00 amRNSFirst Patient Enrolled in Phase II Study - BP-101
25th Jan 20213:30 pmRNSNotice of EGM
5th Jan 20217:00 amRNSRe-Filing of Marketing Authorisation Application
17th Dec 20202:45 pmRNSResult of AGM
27th Nov 20203:08 pmRNSNotice of AGM
9th Oct 20207:00 amRNSAppointment of Chief Business Officer
2nd Oct 202011:06 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSUpdate re Russian Marketing Authorisation
28th Sep 20207:00 amRNSDeath of a Director
21st Sep 20207:00 amRNSInterim Results
14th Aug 202011:05 amRNSSecond Price Monitoring Extn
14th Aug 202011:00 amRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSAnnual Report
14th Apr 20202:05 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSAcquisition of Remaining Minority Interest in IVIX
7th Nov 201912:45 pmRNSAttendance at Bio-Europe Conference
16th Sep 20197:00 amRNSInterim Results
12th Sep 20197:00 amRNSFiling of Marketing Authorisation Application
28th Aug 20197:00 amRNSDirectorate Change
8th Aug 20194:14 pmRNSResult of AGM
8th Aug 20199:05 amRNSSecond Price Monitoring Extn
8th Aug 20199:00 amRNSPrice Monitoring Extension
8th Aug 20197:00 amRNSAGM Statement
26th Jul 20197:00 amRNSDirectorate Change
25th Jul 20194:41 pmRNSSecond Price Monitoring Extn
25th Jul 20194:35 pmRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSAnnual Report and Notice of AGM
23rd Apr 20197:00 amRNSUS and EU Clinical Development Plans
29th Mar 20197:00 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSOperational Update & Additional Investment in IVIX

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.